Zhejiang Medicine Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ETHYL ICOSAPENTATE, with a corresponding US DMF Number 38870.
Remarkably, this DMF maintains an Active status since its submission on October 30, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2024, and payment made on November 10, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II